CoChat
Sign Up
Cited by 815Retinal Diseases and TreatmentsRetinal Imaging and AnalysisOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The Prevalence of Age-related Maculopathy in the Rotterdam Study

Open access
Vingerling, Johannes R., Dielemans, Ida, Hofman, Albert, Grobbee, Diederick E., Hijmering, Michel, Kramer, Constantijn F.L., de Jong, Paulus T.V.M.·1995·Ophthalmology
DOI 10.1016/s0161-6420(95)31034-2
Open this paper in CoChat — free accountOpen PDF

Abstract

Purpose To determine the prevalence of age-related maculopathy in an elderly population in The Netherlands.Methods Fundus photographs of 6251 participants of the Rotterdam Study, a single-center prospective follow-up study in persons 55 to 98 years of age, were reviewed for the presence of drusen, pigmentary abnormalities, and atrophic or neovascular age-related macular degeneration.Results The prevalence of at least one drusen of 63 microns or larger increased from 40.8% in persons 55 to 64 years of age to 52.6% in those 85 years of age or older. Similarly, the prevalence of the following abnormalities increased significantly in these age categories: drusen of 125 microns or larger from 4.8% to 17.5%, retinal pigment epithelial hypopigmentations from 3.5% to 9.0%, and increased retinal pigment from 3.7% to 15.3%. Atrophic or neovascular age-related macular degeneration was present in 1.7% of the total population. Atrophic age-related macular degeneration increased from 0.1% in persons 55 to 64 years of age to 3.7% in those 85 years of age or older. Neovascular age-related macular degeneration increased from 0.1% to 7.4% in these age groups. No sex differences were observed for these lesions.Conclusions The prevalence of atrophic or neovascular age-related macular degeneration is 1.7%. In those 55 years of age or older, the prevalence increases strongly with age and it is similar in men and women. Neovascular age-related macular degeneration was twice as common as atrophic age-related macular degeneration. These findings suggest that age-related maculopathy may be less common in this European population than in similar populations in the United States.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0161-6420(95)31034-2

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 1

  1. Leibowitz, 1980, The Framingham Eye Study monograph, Surv Ophthalmol, 24, 335

Cited by

Sorted by citations

Items 701–800 of 811

Related

See all

Metadata

Authors
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M.
Affiliations
Erasmus MC (NL)
ORCID
Venue
Ophthalmology
Publisher
Elsevier BV
Published
1995-02
Volume
102
Issue
2
Pages
205-210
ISSN
0161-6420 (ISSN-L)
DOI
10.1016/s0161-6420(95)31034-2
OpenAlex
W2165062842
Cited by
815
References
9
Citations by year
2026: 7 · 2025: 4 · 2024: 14 · 2023: 16 · 2022: 15 · 2021: 14 · 2020: 22 · 2019: 12 · 2018: 27 · 2017: 24 · 2016: 19 · 2015: 35 · 2014: 21 · 2013: 33 · 2012: 31
FWCI
21.27
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
age-related maculopathy, age-related macular degeneration, drusen, retinal pigment epithelium, retinal pigment, atrophic macular degeneration, neovascular age-related macular degeneration, prevalence, older adults, sex differences, age-related changes
MeSH terms
Aged, Aged, 80 and over, Female, Follow-Up Studies, Fundus Oculi, Humans, Macular Degeneration, Male, Middle Aged, Netherlands, Photography, Prospective Studies, Retinitis Pigmentosa, Retinal Drusen, Retinal Neovascularization, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review